Radiopharmaceutical CDMO Market Size & Trends Report Segmented by Type (Technetium-99m, Fluorine-18, Leutetium-177, Gallium-68, Actinium-225), Application (Diagnostic, Therapeutic), Phase (Pre-clinical, Clinical, Commercial), Indication (Cardiology, Oncology, Neurology) & Regional Forecasts to 2030

1. Introduction
   • Introduction
   • Market Scope
     • Market Definition
     • Segments Covered
     • Regional Segmentation
   • Research Timeframe
   • Currency Considered
   • Study Limitations
   • Stakeholders
   • List of Abbreviations
   • Key Conferences and Events (2025-2026)
2. Research Methodology
   • Secondary Research
   • Primary Research
   • Market Estimation
     • Bottom-Up Approach
     • Top-Down Approach
   • Market Forecasting
3. Executive Summary
   • Radiopharmaceutical CDMO Market Snapshot (2025-2030)
   • Segment Overview
   • Regional Snapshot
   • Competitive Insights
5. Advancements in nuclear medicine
6. Increasing outsourcing to reduce costs and accelerate time-to-market
7. Restraints
   • Regulatory and quality compliance challenges
   • Supply chain and isotope availability issues
8. Opportunities
   • Expansion into emerging markets
   • Technological innovations in manufacturing
   • Strategic partnerships and end-to-end solutions
9. Key Market Trends
   • Investment in regional distribution networks to overcome logistical challenges
   • Growing focus on theranostics and personalized treatments in oncology
10. Unmet Market Needs
11. Industry Speaks
"5">
12. Global Radiopharmaceutical CDMO Market Size & Forecast (2023-2030), By Radiopharmaceutical Type, USD Million
    • Introduction
    • Technetium-99m
    • Fluorine-18
    • Leutetium-177
    • Gallium-68
    • Actinium-225
    • Others
13. Global Radiopharmaceutical CDMO Market Size & Forecast (2023-2030), By Application, USD Million
    • Introduction
    • Diagnostic Radiopharmaceuticals
      • PET Radiopharmaceuticals
      • SPECT Radiopharmaceuticals
    • Therapeutic Radiopharmaceuticals
      • Alpha Emitters
      • Beta Emitters
      • Other Therapeutic Radiopharmaceuticals
"7">
14. Global Radiopharmaceutical CDMO Market Size & Forecast (2023-2030), By Phase, USD Million
    • Introduction
    • Pre-clinical
    • Clinical
    • Commercial
15. Global Radiopharmaceutical CDMO Market Size & Forecast (2023-2030), By Indication, USD Million
    • Introduction
    • Oncology
    • Cardiovascular Disorders
    • Neurological Disorders
    • Others
16. Global Radiopharmaceutical CDMO Market Size & Forecast (2023-2030), By Region, USD Million
    • Introduction
    • North America Radiopharmaceutical CDMO Market Size & Forecast (2023-2030), By Country, USD Million
      • US
        • Market Size & Forecast, By Radiopharmaceutical Type (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Mai>Market Size & Forecast, By Indication (USD Million)
      • Canada
        • Market Size & Forecast, By Radiopharmaceutical Type (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Phase (USD Million)
        • Market Size & Forecast, By Indication (USD Million)
    • Europe Radiopharmaceutical CDMO Market Size & Forecast (2023-2030), By Country, USD Million
      • UK
        • Market Size & Forecast, By Radiopharmaceutical Type (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Phase (USD Million)
        • Market Size & Forecast, By Indication (USD Million)
      • Germany
        • Market Size & Forecast, By Radiopharmaceutical Type (USD Million)
        • Market Size & Forecast, By>Market Size & Forecast, By Indication (USD Million)
      • France
        • Market Size & Forecast, By Radiopharmaceutical Type (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Phase (USD Million)
        • Market Size & Forecast, By Indication (USD Million)
      • Italy
        • Market Size & Forecast, By Radiopharmaceutical Type (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Phase (USD Million)
        • Market Size & Forecast, By Indication (USD Million)
      • Spain
        • Market Size & Forecast, By Radiopharmaceutical Type (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Phase (USD Million)
        • Market Size & Fo& Forecast, By Radiopharmaceutical Type (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Phase (USD Million)
        • Market Size & Forecast, By Indication (USD Million)
    • Asia Pacific (APAC) Radiopharmaceutical CDMO Market Size & Forecast (2023-2030), By Country, USD Million
      • China
        • Market Size & Forecast, By Radiopharmaceutical Type (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Phase (USD Million)
        • Market Size & Forecast, By Indication (USD Million)
      • Japan
        • Market Size & Forecast, By Radiopharmaceutical Type (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Phase (USD Million)
        • Market>Market Size & Forecast, By Radiopharmaceutical Type (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Phase (USD Million)
        • Market Size & Forecast, By Indication (USD Million)
      • Rest of Asia Pacific
        • Market Size & Forecast, By Radiopharmaceutical Type (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Phase (USD Million)
        • Market Size & Forecast, By Indication (USD Million)
    • Latin America (LATAM) Radiopharmaceutical CDMO Market Size & Forecast (2023-2030), USD Million
      • Market Size & Forecast, By Radiopharmaceutical Type (USD Million)
      • Market Size & Forecast, By Application (USD Million)
      • Market Size & Forecast, By Phase (USD Million)
      • Market Size &p; Africa (MEA) Radiopharmaceutical CDMO Market Size & Forecast (2023-2030), USD Million
        • Market Size & Forecast, By Radiopharmaceutical Type (USD Million)
        • Market Size & Forecast, By Application (USD Million)
        • Market Size & Forecast, By Phase (USD Million)
        • Market Size & Forecast, By Indication (USD Million)
      • Competitive Landscape
        • Key Players and their Competitive Positioning
          • Key Player Comparison
          • Segment-wise Player Mapping
          • Market Share Analysis (2024)
          • Company Categorization Matrix
            • Dominants/Leaders
            • New Entrants
            • Emerging Players
            • Innovative Players
          • Key Strategies Assessment, By Player (2022-2025)
            • New Service Launches
            • Partnerships, Agreements, & Collaborations
            • Mergers & Acquisitions
            • Geographic Expansion

11. Company Profiles*

(Business Overview, Financial Performance**, Products Offered, Recent Developments)

• Cardinal Health
• Eckert & Ziegler
• NorthStar Medical Radioisotopes
• Nucleus RadioPharma
• PharmaLogic
• DuchemBio, Co., Ltd.
• Minerva Imaging
• AtomVie
• Eczacba-Monrol
• Seibersdorf Labor GmbH
• Other Prominent Players

Note: *Indicative list

**For listed com